Background: Association between plasminogen activator inhibitor-1 (PAI-1) rs1799889 polymorphism and venous thromboembolism (VTE) were explored by many previous studies, yet the findings of these studies were conflicting.
thrombosis via inhibiting biological activities of tissue plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA). 6 Previous basic researches showed that blockage of PAI-1 could lead to thrombus degradation, whereas activation of PAI-1 could accelerate thrombus formation. 7, 8 So if a gene polymorphism could alter the expression level or protein structure of PAI-1, it is possible that this polymorphism may also affect individual susceptibility to thrombotic disorders like VTE.
In recent years, many investigations reported findings regarding potential associations between PAI-1 rs1799889 A/G polymorphism and VTE. [9] [10] [11] [12] Nevertheless, these findings were somehow inconsistent.
In this meta-analysis, we aimed to better clarify the relationship between PAI-1 rs1799889 A/G polymorphism and VTE. We will also perform comprehensive analyses to investigate the effects of ethnic background, type of disease, and established risk factors of VTE (Factor V Leiden mutation, cancer status, and recent major surgery) on genetic association between PAI-1 rs1799889 A/G polymorphism and VTE.
| MATERIALS AND METHODS
This meta-analysis was written in accordance with PRISMA guideline. 13 We also created an Open Science Framework (osf.io) account to make this meta-analysis more publicly available.
| Literature search and inclusion criteria
We searched PubMed, Web of Science, Embase, and CNKI using the following key words: "plasminogen activator inhibitor-1," "PAI-1," F I G U R E 1 Flowchart of study selection for the present study "plasminogen activator inhibitor 1," "PAI1," "serpin family E member 1," "SERPINE1," "polymorphism," "variant," "variation," "mutation," "SNP," "venous thromboembolism," "VTE," "deep vein thrombosis,"
"DVT," "pulmonary embolism," and "PE." The latest literature searching update was conducted in June 2019.
To be included in this meta-analysis, some criteria must be met: (b) studies that were not carried out in humans; (c) case reports or case series; (d) reviews and comments. If we found repeated publications during literature searching, only the most comprehensive study was included for analyses. The authors used Newcastle-Ottawa scale (NOS) to assess the quality of eligible studies. 14 The score range of NOS is between zero and nine, when a study got a score of seven or more, we considered that the methodology of this study is good.
| Data extraction and quality assessment
Two authors extracted data and assessed quality of eligible publications. The authors wrote to the leadings authors for additional information if essential information was found to be incomplete.
| Statistical analyses
Review Manager was used to combine the results of eligible studies.
Z test was employed to assess whether PAI-1 rs1799889 A/G polymorphism was significantly associated with VTE, with the statistical significance P level set at .05. We used I 2 statistics to assess betweenstudy heterogeneities. We used Random-effect models (DerSimonian-Laird method) to combine the results if I 2 is larger than 50%. Otherwise, fixed-effect models (Mantel-Haenszel method) were used to combine the results. We also conducted subgroup analyses by ethnicity of participants, type of disease and whether the study subjects had established risks of VTE. We examined the stability of combined results by deleting one study each time and combining the results of the remaining studies. We used funnel plots to estimate whether our combined results may be influenced by publication biases.
This article does not contain any studies with human participants or animals performed by any of the authors, thus ethical approval is not required.
3 | RESULTS
| Characteristics of included studies
One thousand eight hundred and twenty-nine studies were identified by our comprehensive literature searching. One hundred and thirtythree studies were retrieved for eligibility assessment after exclusion of irrelevant and duplicate articles. Another eighty-five articles were further excluded by us because these articles did not meet the inclusion criteria that were set forth for this meta-analysis. Totally fortheight studies containing 5731 cases and 9075 controls were ultimately included in this meta-analysis (see Figure 1 ). Table 1 presented essential data extracted from included studies. Table 2 ).
| Meta-analysis results
We also performed stratified analyses to explore the effects of established risk factors of VTE on observed genetic associations between PAI-1 rs1799889 A/G polymorphism and VTE, and we found positive results in these with Factor V Leiden mutation, whereas no any significant associations were detected in these with cancer or these who recently had a major surgery operation.
| Sensitivity analyses
We examined the stability of combined results by deleting one study each time and combining the results of the remaining studies. The trends of associations remained consistent in sensitivity analyses, which indicated that the combined results were statistically stable.
| Publication biases
Funnels plots were employed to estimate whether our combined results may be influenced by publication biases. Funnel plots of every comparison were symmetrical, which indicated that the combined results were unlikely to be seriously impacted by overt publication biases (see Figure S1 ).
| DISCUSSION
The A/G variant of rs1799889 polymorphism is associated with a guanosine insertion at the −675 site of the PAI. 15 Past pre-clinical studies also demonstrated that the transcriptional activity of A allele was significantly higher than that of the G allele. 16 conflicting. Thus, this meta-analysis was performed by us to more comprehensively analyze relationship between rs1799889 polymorphism and VTE. The combined results demonstrated that PAI-1 rs1799889 A/G polymorphism was significantly associated with VTE in both Caucasians and East Asians. Further analyses obtained similar positive findings in these with DVT and these with Factor V Leiden mutation. The trends of associations remained consistent in sensitivity analyses, which indicated that the combined results were stable.
To better understand the combined results of this meta-analysis, some points should be considered. Firstly, the etiology of VTE is complex, so we recommend future studies to conduct haplotype analyses and investigate gene-gene interactions to more precisely analyze the effects of genetics on disease susceptibility. 18 Secondly, environmental factors may also affect relationship between PAI-1 rs1799889 A/G polymorphism and PAI. Unfortunately, the majority of eligible publications only focused on genetic associations, so we could not estimate genetic-environmental interactions in this meta-analysis. 19 Thirdly, this meta-analysis was designed to assess associations between all PAI-1 polymorphisms and VTE. Nevertheless, only rs1799889 polymorphism was analyzed by us because no any other PAI-1 polymorphisms were studied by at least two different studies. Fourthly, it should be noted that in 2014, Wang et al also performed a metaanalysis to investigate association between rs1799889 polymorphism and VTE. 20 Since many related articles were published after this metaanalysis, an updated study like ours is warranted. The sample size of the current meta-analysis was around 50% larger than that of the previous meta-analysis (14 806 subjects vs 9254 subjects), so our work should be considered as a valuable supplement to pre-existing literatures. Consistent with findings of the previous meta-analysis, we also confirmed that rs1799889 polymorphism was associated with an elevated susceptibility to VTE in both Caucasians and East Asians. The results of these two meta-analyses indicated that PAI-1 rs1799889
polymorphism might serve as one of the predisposing factors of VTE. Subgroup analyses by established risk factors of VTE were also further performed by us. Nevertheless, since these analyses were only based on limited number of participants, the findings of these analyses should be considered as only exploratory, and further experimental studies should try to confirm these results.
Besides, more stratified analyses should also be conducted by future meta-analyses if there are sufficient data to support additional analyses for other established risk factors of VTE. Fifthly, although we also conducted subgroup analyses by type of disease in this meta-analysis, it is noteworthy that studies only focused on PE were scare, so the results of subgroup analyses by type of disease should also be taken as exploratory. Future studies are still needed to confirm these findings.
Some limitations of this meta-analysis should also be mentioned.
Firstly, the results regarding associations between polymorphisms in PAI-1 rs1799889 polymorphism and VTE were based on combining unadjusted findings of eligible publications due to lack of raw data. 21 Secondly, gray literatures were not searched. So although funnel plots of every comparison were symmetrical, it is still possible that the combined results may be affected by publication biases. 22,23
| CONCLUSIONS
In summary, the combined results of this meta-analysis proved that PAI-1 rs1799889 A/G polymorphism may serve as one of the predisposing factors of VTE in both Caucasians and East Asians, especially in these with DVT and these with Factor V Leiden mutation.
Further studies with larger sample sizes still need to verify our findings. Besides, given that the pathogenesis of VTE is complex, despite our comprehensive analyses, we still recommend further studies to explore gene-gene interactions and gene-environmental interactions in the development of VTE.
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